-

Eurofins MET Laboratories Opens New Safety, EMC, Wireless, and Renewable Energy Laboratory in the Boston Tech Corridor

BOSTON--(BUSINESS WIRE)--Eurofins MET Laboratories, part of the Eurofins Electrical & Electronics global network, announces the opening of its new state-of-the-art 60,000-square-foot testing laboratory in Littleton, Massachusetts – a prime location in the Boston innovation corridor. Positioned at the epicenter of New England's med-tech, wireless innovation, clean energy, and advanced electronics ecosystem, the capabilities of this laboratory further position Eurofins MET Laboratories as the premier regional partner for high-stakes, regulated products. It meets heightened demand from companies developing life-saving medical devices, next-gen wireless-enabled products, renewable energy solutions, and beyond - offering faster turnaround times and deeper technical support, accelerating time-to-market while ensuring compliance.

The capabilities of the new laboratory complement Eurofins MET Laboratories’ robust network of Safety, Environmental and EMC testing laboratories across six other locations in the United States, including Maryland, North Carolina, Texas, and California. This laboratory also houses a 10-metre semi-anechoic chamber, adding to the 10-metre chambers located in Eurofins MET Laboratories’ Texas and California laboratories among others.

Highlights of the new laboratory include:

  • Advanced EMC and wireless testing by a 10-metre semi-anechoic chamber for comprehensive compliance to FCC, ISED, CE, RED, and global standards
  • Product Safety Testing, offering testing and certification for multiple industries and product categories, including medical, information technology, laboratory and measurement, industrial, military, hazardous locations, appliances and electronics, safety field evaluations, and more
  • Dedicated renewable energy testing covering electrical safety, EMC, performance, and environmental resilience to support the transition to sustainable power
  • Full environmental and performance simulation to validate durability and reliability under real-world and harsh conditions
  • Purpose-built spaces optimised for the most demanding projects in medical, wireless/consumer electronics, industrial, renewable energy, and emerging tech sectors to streamline complex workflows and minimise delays

About Eurofins Consumer Product Testing –

Eurofins Consumer Product Testing is part of the Eurofins network and is a global leader in supporting brands, retailers and manufacturers worldwide in bringing safe, compliant and high-quality consumer products to market. It offers comprehensive, end-to-end testing, inspection and certification services designed around customer needs and product lifecycle requirements.

With expertise across Softlines & Hardlines, Cosmetics & Personal Care, Electrical & Electronics, and Sustainability Services, Eurofins Consumer Product Testing delivers integrated testing, inspection and certification services across supply chains, helping customers manage risk, meet regulatory expectations and build consumer trust.

Contacts

For further information:

Carry Chiamvixay
carry.chiamvixay@cpt.eurofinsus.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

For further information:

Carry Chiamvixay
carry.chiamvixay@cpt.eurofinsus.com

More News From Eurofins

Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd February to 06th February 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/02/2026 FR0014000MR3 10 000 68.3375 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/02/2026 FR0014000MR3 10 000 67.9091 XPAR EUROFINS SCIENTIFIC 529900JEHFM...

Eurofins Viracor BioPharma Expands Bioanalytical Capabilities

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical...

Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is pleased to announce that its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a research and development collaboration project focused on advancing a transformative approach for next-generation ADC (antibody-drug conjugate) production to meet the growing demand for targeted therapeutics. As part of this initia...
Back to Newsroom